Join the Ulcerative Colitis group to help and get support from people like you.
Ulcerative Colitis News
Related terms: Colitis, Ulcerative, UC, Colitis Ulcerosa
FDA Approves Tremfya for Ulcerative Colitis
MONDAY, Sept. 16, 2024 – The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis. Tremfya is the...
RSV Infection With Inflammatory Bowel Disease Ups Risk for Hospitalization
WEDNESDAY, Aug. 28, 2024 – Adult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization, according to a study...
Televisit Outpatient Care Feasible for Inflammatory Bowel Disease
FRIDAY, Aug. 23, 2024 – Televisit-delivered outpatient care for inflammatory bowel disease (IBD) is not associated with a higher risk for IBD-related hospitalization, according to a study published...
4 Tips to Keeping Your Gut Healthy and Free of IBD
TUESDAY, Aug. 6, 2024 – Almost 2.4 million Americans are thought to suffer from the pain and disability of inflammatory bowel disorder (IBD), a type of autoimmune illness that includes ulcerative...
'Microrobot' Pills Eased IBD in Mice, Paving Way for Human Testing
FRIDAY, June 28, 2024 – A new "microrobot" pill may help tame inflammatory bowel disease (IBD), a new study in mice suggests. The pill significantly reduced IBD symptoms in mice and promoted the...
FDA Approves Skyrizi (risankizumab-rzaa) for Ulcerative Colitis
NORTH CHICAGO, Ill., June 18, 2024 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved Skyrizi® (risankizumab-rzaa) for adults with moderately ...
No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD Patients
TUESDAY, June 11, 2024 – There is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD)...
Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease
FRIDAY, May 3, 2024 – Among postmenopausal women with inflammatory bowel disease (IBD), there is no higher risk for cardiovascular disease (CVD) compared with women without IBD, although the risk...
Study IDs Risk Factors for Extraintestinal Manifestations of IBD
WEDNESDAY, April 17, 2024 – Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD), according to a study...
Higher Vitamin D Levels Cut Bowel Resection Risk With IBD
WEDNESDAY, April 3, 2024 (HealthDay News) – An increased serum level of 25-hydroxyvitamin D (25[OH]D) is independently associated with a lower risk for bowel resection with inflammatory bowel ...
FDA Approves Simlandi (adalimumab-ryvk), an Interchangeable Biosimilar to Humira
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 24, 2024 (GLOBE NEWSWIRE) – Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:...
Baby's Diet Could Cut Lifetime Odds for Crohn's, Colitis
WEDNESDAY, Jan. 31, 2024 – Toddlers are famously picky eaters, but parents may be doing their young child's future gut a huge favor if they insist on a healthy diet. New research shows that toddlers...
Higher Use of Any Rx Medications Seen Years Before IBD Diagnosis
FRIDAY, Jan. 19, 2024 – Individuals with inflammatory bowel disease (IBD) universally show increased prescription medication use years before diagnosis, according to a study published in the...
Malnutrition Often Seen in Patients Treated for IBD
FRIDAY, Jan. 12, 2024 – Some patients seen in an inflammatory bowel disease (IBD) clinic screen positive for malnutrition, according to a research letter published online Nov. 20 in Gastro Hep ...
Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease
FRIDAY, Jan. 12, 2024 – Perfluoroalkyl and polyfluoroalkyl substance (PFAS) exposure is associated with later occurrence of inflammatory bowel disease (IBD), according to a research letter published...
Further information
Related condition support groups
Ulcerative Colitis - Active, Colitis
Related drug support groups
Humira, clonidine, hydrocortisone, Remicade, Stelara, Entyvio, Xeljanz, Skyrizi, dexamethasone, adalimumab, budesonide, ustekinumab